Comments on: Wotta Deal! Investing In A Date-Rape Drug http://www.pharmalot.com/2007/05/wotta-deal-investing-in-a-date-rape-drug/ News, Comment and Conversation Fri, 10 Feb 2012 19:40:40 +0000 http://wordpress.org/?v=2.6.2 By: Gail Eskelsen http://www.pharmalot.com/2007/05/wotta-deal-investing-in-a-date-rape-drug/#comment-14466 Gail Eskelsen Thu, 28 Jun 2007 03:38:34 +0000 http://www.pharmalot.com/2007/05/wotta-deal-investing-in-a-date-rape-drug/#comment-14466 Hello again, I copied the press release from Narcolepsy Network to you prematurely this morning prematurely. It is still under review. Could you go no further with that information until otherwise notified. Thanks so much! Hello again,

I copied the press release from Narcolepsy Network to you prematurely this morning prematurely. It is still under review. Could you go no further with that information until otherwise notified.

Thanks so much!

]]> By: Drug Law Blog http://www.pharmalot.com/2007/05/wotta-deal-investing-in-a-date-rape-drug/#comment-3577 Drug Law Blog Fri, 01 Jun 2007 01:19:36 +0000 http://www.pharmalot.com/2007/05/wotta-deal-investing-in-a-date-rape-drug/#comment-3577 <strong>Xyrem: Fighting Off the Taboo of Schedule I...</strong> The New York Times reports today on Palo Alto-based Jazz Pharmaceuticals, which makes a drug called Xyrem to treat narcolepsy. The striking thing about this drug: it's also the Schedule I substance gamma hydroxybutyrate, better known as the party/date... Xyrem: Fighting Off the Taboo of Schedule I…

The New York Times reports today on Palo Alto-based Jazz Pharmaceuticals, which makes a drug called Xyrem to treat narcolepsy. The striking thing about this drug: it’s also the Schedule I substance gamma hydroxybutyrate, better known as the party/date…

]]>